Leucine kinetics during simultaneously administered insulin and dexamethasone in preterm infants with severe lung disease

Pediatric Research

Volumn 49, Issue 3, 2001, Pages 373-378

  Van Beek, Ron H T ^a   Zimmermann, Luc J I ^b   Vergunst van Keulen, Jolande G ^b   Carnielli, Virgilio P ^d   Wattimena, Darcos J L D ^c   Van Goudoever, Johannes B ^b   Sauer, Pieter J J ^e  

^a Ignatius Hospital   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CORTICOSTEROID; DEXAMETHASONE; INSULIN; LEUCINE; MONOCOMPONENT INSULIN;

AMINO ACID METABOLISM; ARTICLE; CATABOLISM; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFECT; HUMAN; INFANT; INSULIN TREATMENT; KINETICS; LUNG DISEASE; PREMATURITY; PRIORITY JOURNAL; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT; WEIGHT GAIN;

EID: 0035096781     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200103000-00011     Document Type: Article

References (31)

1. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia
2. Early-postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: A multicenter clinical trial
3. Controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia
4. Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia
5. Catabolic effect of dexamethasone in the preterm baby
6. The influence of acute physiological increments of cortisol on fuel metabolism and insulin binding to monocytes in normal humans
7. Increased proteolysis: An effect of increases in plasma cortisol within the physiologic range
8. Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans
9. Glucocorticoids increase leucine oxidation and impair leucine balance in humans
10. Effect of dexamethasone on protein metabolism in infants with broncho-pulmonary dysplasia
11. Physiological hypercortisolemia increases proteolysis, glutamine and alanine production
12. Glucocorticoid action on protein synthesis and protein breakdown in isolated skeletal muscles
13. Influence of glucocorticoids on skeletal muscle proteolysis in normal and diabetic-adrenalectomized eviscerated rats
14. Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man
15. Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo
16. Dissociation of the effects of epinephrine and insulin on glucose and protein metabolism
17. Contribution of insulin resistance to catabolic effect of prednisone on leucine metabolism in humans
18. 13C]leucine infusion in man: A method for measuring human intracellular leucine tracer enrichment
19. Use of reciprocal pool specific activities to model leucine metabolism in humans
20. Intrauterine growth of life-born Caucasian infants at sea level: Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation
21. Continuous infusion of insulin in hyperglycemic low-birth weight infants receiving parenteral nutrition with and without lipid emulsion
22. Exogenous insulin reduces proteolysis and protein synthesis in extremely low birth weight infants
23. The limitation to and valid use of C-peptide as a marker of the secretion of insulin
24. Insulin-like growth factor has failed to reverse corticosteroid-induced protein catabolism in growing piglets
25. Growth hormone does not prevent catabolic side effects of dexamethasone in extremely low birth weight preterm infants with bronchopulmonary dysplasia: A pilot study
26. Human growth hormone prevents the protein catabolic side effects of prednisone in humans
27. Growth hormone and lean tissue catabolism during long term glucocorticoid treatment
28. Effects of short term administration of recombinant human growth hormone to elderly people
29. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor by use of both agents simultaneously
30. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats
31. Increased mortality associated with growth hormone treatment in critically ill adults